Marijuana abuse is very prominent among pregnant women. Although, marijuana cannabinoids have been shown to exert immunosuppression in adults, virtually nothing is known about the effects of marijuana use during pregnancy on the developing immune system of the fetus and during post-natal life. We noted that murine fetal thymus expressed high levels of CB1 and CB2 receptors. Moreover, perinatal exposure to delta-9-tetrahydrocannabinol (THC), had a profound effect on the fetus as evidenced by a decrease in thymic cellularity on gestational day 16, 17, 18 and post-gestational day 1, and marked alterations in T cell subpopulations. These outcomes were reversed by CB1/ CB2 antagonists, suggesting that THC-mediated these effects through cannabinoid receptors. Thymic atrophy induced in the fetus correlated with caspase-dependent apoptosis in thymocytes. Thymic atrophy was the result of direct action of THC and not based on maternal factors inasmuch as THC was able to induce T cell apoptosis in vitro in fetal thymic organ cultures. Interestingly, perinatal exposure to THC also had a profound effect on the immune response during post-natal life. Peripheral T cells from such mice showed decreased proliferative response to T cell mitogen as well as both T cell and antibody response to HIV-1 p17/p24/gp-120 antigens. Together, our data demonstrate for the first time that perinatal exposure to THC triggers profound T cell dysfunction thereby suggesting that the offspring of marijuana abusers who have been exposed to THC in utero may be at a higher risk of exhibiting immune dysfunction and contracting infectious diseases including HIV.
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5 that perinatal exposure to THC may affect fetal brain development and therefore alter behavioral responses of the offspring later in life Vela et al., 1995) . A few studies even suggested that children exposed to marijuana in utero may be at a higher risk of developing certain cancers, such as neuroblastoma (Bluhm et al., 2006) and leukemia (Robison et al., 1989) , although those findings are still somewhat controversial. Nonetheless, virtually nothing is known about the consequences of perinatal exposure to THC on the offspring's immune system.
In addition, several reports suggest that use of marijuana and other cannabinoids may lead to a higher risk of contracting Human Immunodeficiency Virus (HIV), both directly and indirectly. Indirectly, the "high" experienced by marijuana abusers makes them more likely to adopt risky behavior such as having unprotected sex with HIV-positive individuals (Brodbeck et al., 2006; Drumright et al., 2006) . In addition, studies performed using severe combined immunodeficient mice implanted with human peripheral blood lymphocytes (huPBL-SCID mice) show that THC both induces immunosuppression and increases HIV replication (Roth et al., 2005) , suggesting a more direct link between cannabinoid use and HIV infection. Clearly, more research is needed to determine the consequences of perinatal exposure to cannabinoids on the immune system of the unborn offspring, as well as the risk that the progeny faces of contracting diseases such as HIV.
In the current study, we demonstrate that perinatal exposure to THC can alter T cell development and functions in the neonatal and post-natal stages of life which in turn could potentially have a major impact on susceptibility to infections as well as other immune disorders. 
Detection of CB1 and CB2 expression by RT-PCR
Fetal thymi were harvested on gestational day (GD) 16 and single cell suspensions were prepared and erythrocytes were lysed. RNA was then isolated using the Trizol method according to the manufacturer's protocol (Invitrogen, Carlsbad, CA) . Because CB1 and CB2 are encoded by single exons, we included a DNase digestion step to limit contamination from genomic DNA.
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Cell preparation
We harvested and pooled the thymi from the fetuses or pups from each mother in each treatment group on GD17, GD18 and PD1 due to low yield of thymocytes. On an average, 10 pups were obtained from each mother. Single cell suspensions were then prepared using a laboratory homogenizer (Stomacher, Tekmar, Cincinnati, OH) . Contaminating erythrocytes were lysed by suspending the cells in 3 ml RBC lysing buffer (Sigma Aldrich). After 2 washes in complete RPMI medium, the cellularity was determined using the trypan blue dye exclusion method. The data were expressed as mean viable thymic cellularity per fetus/ pup. This was calculated by dividing the total number of cells in each pooled sample by the total number of fetuses/pups used.
Subchronic in vivo exposure to THC
Pregnant mice (two per group) were treated i.p. with 25 mg/kg THC or vehicle on GD16, and with 10 mg/kg THC or vehicle every day thereafter until they delivered the pups (for a total of 4 injections or 55 mg/kg of THC). One week after the pups were born, the thymi and spleens were harvested, made into single cell suspension. Contaminating RBCs were lysed and cellularity was determined as described above.
Detection of THC-induced apoptosis in vivo
Thymocytes obtained from the fetuses of THC-and vehicle-treated pregnant mice were cultured in vitro in 96-well flat-bottomed plates (1x10 6 cells/well in 0.2 ml of medium) overnight at 37 o C as this method prevents apoptotic cells from being engulfed by phagocytic cells and therefore allows a better detection of apoptosis. The cells were then harvested, washed twice with PBS, JPET #181206 9 fixed at room temperature with 100 μl 4% paraformaldehyde for 30 min, and subsequently stained for apoptosis using the TUNEL method.
Blockade of THC-induced apoptosis in vivo using CB1 and CB2 inhibitors
Pregnant mice (two per group) were treated i.p. with 20 mg/kg of the CB1 antagonist SR141716A or 40 mg/kg of the CB2 antagonist AM630 on GD16. After 1 h, the mice received 50 mg/kg of THC or the vehicle i.p. On GD17, the mothers were sacrificed and the fetuses were harvested and pooled from each mother. The thymocytes were prepared and cultured overnight at 37 o C as described above. The cells were then harvested, fixed and stained for apoptosis using the TUNEL method.
Fetal thymic organ cultures (FTOCs)
FTOCs were prepared by the standard procedure. Briefly, thymic lobes were aseptically removed from 16-day-old fetuses from several pregnant mice. Up to six randomly chosen thymic lobes were placed on each nitrocellulose filter with 45 μm pore size (Millipore, Bedford, MA) and each filter was set in a 24-well plate culture well with 300 μl complete RPMI 1640 medium supplemented with 5% FBS, 2 mM L-glutamine, 100 μM non-essential amino-acids, 1 mM sodium pyruvate, 50 μM β-mercaptoethanol, 100 U/ml penicillin, and 0.1 mg/ ml streptomycin.
Three wells were used for each treatment. THC was added to a final concentration of 5 μM, 10 μM or 20 μM. Control lobes were cultured in medium containing vehicle (DMSO). The thymic lobes were incubated at 37 o C and 6% CO 2 in a water-saturated atmosphere on day 0. Cultures were fed on day 3 by transferring the filters to new wells containing fresh medium with THC or DMSO. On day 6, thymic lobes from each well were harvested, pooled and single cell This article has not been copyedited and formatted. The final version may differ from this version. JPET Fast Forward. Published on August 10, 2011 as DOI: 10.1124 at ASPET Journals on July 9, 2017 jpet.aspetjournals.org Downloaded from 10 suspensions were prepared. After lysis of the erythrocytes and two washes, the cell viability was determined using trypan blue exclusion. The cells were then analyzed for apoptosis using the TUNEL method.
Detection of apoptosis using the TUNEL method
Apoptotic events were quantified at the single cell level using the TUNEL method (Boerhinger-Mannheim, Indianapolis, IN). Briefly, cells were washed with PBS twice and permeabilized on ice for 2 min using 100 μl of 0.1% Triton X-100 in 0.1% sodium citrate. After two additional washes, the cells were incubated with 25 μl of TUNEL reaction composed of FITC-dUTP and TdT at 37 o C with 5% CO 2 . After 1 h, the cells were washed two more times, resuspended in PBS, and fluorescence was determined by flow cytometry.
Assessment of THC-induced activation of caspase-3 and/or -7
Fetal thymocytes harvested from THC-and vehicle-treated mothers were cultured in vitro in 96well flat-bottomed plates (1x10 6 cells/well in 0.1 ml of medium) overnight at 37 o C. The induction of apoptosis was then detected using the Apo-ONE homogeneous caspase-3/7 assay (Promega Corporation, Madison, WI) according to the manufacturer's recommendation. Briefly, 100 μl of a 1:100 substrate / buffer solution was added to the plate. The plate was then shaken for 30 sec and incubated at room temperature for at least 30 min before reading the results on a Wallac Victor 2 instrument (Perkin Elmer, Boston, MA). This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on August 10, 2011 as DOI: 10.1124/jpet.111.181206 at ASPET Journals on July 9, 2017 jpet.aspetjournals.org
Downloaded from

Detection of phenotypic markers on thymocytes
Thymocytes (1x10 6 ) derived from pups of THC-and vehicle-treated mothers were washed with PBS and incubated with anti-CD16/CD32 mAb on ice for 10 min to block the Fc receptors. The cells were subsequently washed and double-stained for CD4 and CD8, using fluorescein isothiocyanate (FITC)-conjugated anti-CD4 mAb and R-phycoerythrin (PE)-conjugated anti-CD8 mAb (Pharmingen, San Diego, CA), by incubating on ice for 30 min. The cells were then analyzed using a flow cytometer. Absolute numbers for each marker were calculated based on total cell numbers determined by trypan blue exclusion and frequency of each cell population determined by flow cytometry.
Effect of perinatal exposure to THC on the proliferative response of splenocytes and thymocytes to mitogens
Splenocytes and thymocytes collected from pups born to vehicle-or THC-treated mothers (5x10 5 in 100 μl) were cultured in 96-well plates with complete RPMI 1640 medium containing 10% FBS, 2 mM L-glutamine, 50 μM β-mercaptoethanol, 100 U/ml penicillin, and 0.1 mg/ml streptomycin and either left unstimulated or stimulated with 2 μg/ml concanavalin A (Con A) (Sigma Aldrich) or LPS (5 μ g/ml) or 5 μg/ml anti-CD3 mAbs for 48 h. Eight hours prior to the end of the assay, the cells were pulsed with 2 μCi of [ 3 H]-thymidine (GE Healthcare, Piscataway, NJ). DNA synthesis was determined by β-scintillation counting.
Effect of perinatal exposure to THC on post-natal (at adult stage) immune response to
HIV-1 p17/p24/gp-120
This article has not been copyedited and formatted. The final version may differ from this version.
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Pregnant mice were treated i.p. with 50 mg/kg THC or vehicle on GD16 as described above.
Five weeks after the pups were born, they were injected with 5 μg of HIV-1 p17/p24/gp-120 (Prospec Technogene) emulsified in complete Freunds adjuvant (CFA) in each rear footpad. One week later, the mice were sacrificed and draining popliteal lymph nodes (LNs) were harvested and made into a single cells suspension. The viable cellularity was determined using the trypan blue dye exclusion method. The LN cells were then plated and left unstimulated or re-stimulated in vitro with 25 μg/ml p17/p24/gp-120 for 72 h. Eight hours prior to the end of the assay, the cells were pulsed with 2 μCi of 3 H-thymidine. DNA synthesis was determined by β-scintillation counting.
Detection of HIV-1 p17/p24/gp-120-specific Abs by ELISA in mice exposed prenatally to THC Pregnant mice were treated i.p. with 50 mg/kg THC or the vehicle on GD16. Five weeks after the pups were born, they were injected with 5 μg of HIV-1 p17/p24/gp-120 emulsified in complete Freunds adjuvant (CFA) in each rear footpad. One week later, serum samples were screened for Abs using ELISA. High binding (2HB) Immulon microtiter plates (VWR) were coated with 50 μl of HIV-1 p17/p24/gp120 peptide (200 ng/ml) in 100mM NaHCO 3 coating buffer, pH 9.6, for 2 h at room temperature and incubated overnight at 4 o C. After blocking for 1 h with 2% BSA, serum samples diluted in 1% BSA and 0.05% Tween 20 (100 μl/well) were then plated and incubated at room temperature for 2 h. p17/p24/gp-120-specific Abs were then detected by incubating with Horseradish Peroxidase (HRP)-conjugated anti-mouse IgG and ABTS (Sigma Aldrich). The colorimetric change was measured at 405 nm on a Wallac Victor 2 instrument. This article has not been copyedited and formatted. The final version may differ from this version.
Statistical analysis
All statistical analyses were performed using GraphPad prism 4. One-way and two-way ANOVA analyses were carried out to compare experimental groups with controls as detailed in figure legends. Two-tailed unpaired t-test was also used where appropriate. The statistical significance was indicated by asterisk as follows: *p 
Results
Thymocytes from gestational day (GD) 16 fetuses express CB1 and CB2 mRNA
To investigate if perinatal exposure to THC affects the fetal thymus, we first examined whether GD16 fetal thymocytes exhibit CB1 and CB2 cannabinoid receptors. To this end, we performed RT-PCR using RNA extracted from thymocytes of GD16 fetuses, and used RNA from adult thymocytes for comparison. As shown in Fig. 1 , we found a similar pattern of expression of CB1 and CB2 in fetal thymocytes when compared to adult thymocytes, with CB2 being expressed at much higher levels than CB1.
Acute perinatal exposure to THC induces apoptosis and alterations in T cell subsets of the fetal thymus
In order to determine whether THC has an influence on thymic development, we injected pregnant C57BL/6 mice intraperitoneally with THC (20 mg/kg or 50 mg/kg) or vehicle on GD16. Analysis of the fetal thymi on GD17 revealed a dose-dependent decrease in thymic cellularity ( Fig. 2A ) indicative of thymic atrophy. In addition, THC treatment led to a decrease in the percentages of single positive (SP) CD8 + T cells at both doses and double-positive (DP) T cells only at the higher dose ( Fig. 2B ). Moreover, we noted an increase in the proportions of SP CD4 + T cells and double-negative (DN) T cells at higher doses of THC ( Fig. 2B ). When we enumerated the absolute numbers of various T cell subpopulations ( Fig 2C) , we found that all subsets were decreased following THC exposure in a dose-dependent manner except the SP CD4 + T cells. doses of THC, the percentage of apoptosis was modest, which could be because the cells that undergo apoptosis in vivo are rapidly phagocytosed and cleared (Kamath et al., 1997) . It has to be noted that thymocytes from vehicle-treated animals show significant levels of apoptosis. This is not surprising as thymocytes, which comprise a majority of immature double-negative T cells spontaneously undergo apoptosis when they are cultured in vitro (Kamath et al., 1997) .
Together these data suggested that acute perinatal exposure to THC affects T cell development in the thymus of the fetus. Also, these data suggested that THC may mediate its effect, at least in part, through induction of apoptosis.
THC-induced apoptosis in fetal thymocytes is cannabinoid receptor-mediated
Next, we investigated whether THC mediated its effects on the fetus through CB1 and CB2 receptors or through non-specific mechanisms such as maternal-derived factors. To this end, pregnant mice were pre-treated with CB1 ( Fig Together these data suggested that THC-induced apoptosis was resulting from activation of both the CB1 and the CB2 receptors.
Alterations of thymic cellularity and T-cell subpopulations persist several days after acute perinatal exposure to THC
In order to determine whether the effects of THC on T cell development in the thymus were transient or if they persisted beyond the first 24 hours following exposure, pregnant mice This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on August 10, 2011 as DOI: 10.1124/jpet.111.181206 at ASPET Journals on July 9, 2017 jpet.aspetjournals.org Downloaded from received a single injection of THC (50 mg/kg) on GD16 and fetal thymi were harvested on GD18 and PD1. Fetuses from vehicle-treated mice showed an increase in thymic cellularity from GD17 to PD1 consistent with normal thymic development ( Fig. 4A ). Thymi harvested from the fetus of THC-treated mothers showed decreased cellularity at all days tested (Fig. 4A ). In addition, THCinduced apoptosis was still detectable on GD18 ( Fig. 4D ) and PD1 (Fig. 4H ), by TUNEL staining. We also noted that the THC-induced apoptosis was mediated by caspases as shown by use of caspase-3/7 assay (Fig. 4E, I) . Although, we couldn't detect any major changes in the percentages of cells found in each T cell subset on GD 18, there were significant changes seen on PD1 ( Fig. 4B, F) . However, when we investigated the absolute number of T cell subsets, we noted a consistent decrease in the absolute numbers of SP CD8 + , DP CD4 + CD8 + , and DN T cells both on GD18 ( Fig. 4C ) and PD1 (Fig. 4G ), similar to GD 16 ( Fig 2C) . Together, these data suggested that the a single perinatal exposure to THC around the time of T cell development can have a profound effect on T cell development which persists until the birth of the pups.
Exposure of Fetal Thymic Organ Cultures (FTOCs) to THC results in decreased cellularity and induction of apoptosis.
In order to exclude the possibility that THC-induced apoptosis was the result of the stress or due to maternal derived factors, we investigated the direct effects of THC on developing T cells using FTOCs. Fetal thymi were harvested on GD16 and cultured in the presence of various concentrations of THC or the vehicle for 6 days with a media change on day 3. Analysis at the end of the treatment showed a dose-dependent decrease in thymic cellularity upon exposure to THC (Fig. 5A ), which correlated with an increase in apoptosis, particularly at higher doses of This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on August 10, 2011 as DOI: 10.1124/jpet.111.181206 at ASPET Journals on July 9, 2017 jpet.aspetjournals.org Downloaded from THC ( Fig. 5B) . At lower doses, the apoptosis was not demonstrable which suggested that in FTOC, the low levels of apoptosis may not be detectable due to phagocytosis of apoptotic cells or it is also likely that THC may inhibit T cell differentiation. Together, these data suggested that the effects seen in vivo on the fetus may result from direct exposure to THC leading to apoptosis.
Acute perinatal exposure to THC results in decreased immune response to HIV-1 p17/p24/gp-120
Illegal drug abuse, including marijuana abuse, has been linked to a higher risk of contracting HIV. However, little is known about the risk faced by children exposed to marijuana in utero. In order to shed some light on this question, C57BL/6 pregnant mice were treated with an acute dose of THC or the vehicle on GD16 and allowed to deliver their pups. Five weeks after birth, the pups were injected in each rear footpad with HIV-1 p17/p24/gp-120 emulsified in CFA or left untreated (naïve) and allowed to rest for one week. Serum and draining lymph nodes were then collected and used to measure HIV-1 p17/p24/gp-120 specific antibodies and the proliferative response to re-stimulation with HIV-1 p17/p24/gp-120 in vitro respectively. THCexposed animals showed lower serum titers of HIV-1 p17/p24/gp-120-specific antibodies when compared to animals exposed to vehicle (Fig. 6A ). In addition, THC-exposed lymphocytes had a lower proliferative response to HIV-1 p17/p24/gp-120 re-stimulation in vitro, when compared to their vehicle-exposed counterpart (Fig. 6B ). Together, these data suggested that perinatal exposure to THC decreases the immune response to HIV antigens. This article has not been copyedited and formatted. The final version may differ from this version.
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Effect of subchronic perinatal exposure to THC on the thymus and spleen of 1-week old pups
To this point, we noted that acute perinatal exposure to THC has a negative effect on the immune system of the progeny that can still be detected up to five weeks into life. However, in humans, perinatal exposure to THC is more likely to be chronic than acute. Therefore, we investigated the effects of subchronic perinatal exposure to THC on the thymus and spleen of the progeny. To this end, C57BL/6 pregnant mice were injected with 25 mg/kg THC or the vehicle on GD16, and 10 mg/kg THC or the vehicle every day thereafter until the pups were born, for a total of four injections or 55 mg/kg THC. One week after the pups were born, thymi and spleens were harvested. The results showed that subchronic perinatal exposure to THC leads to thymic ( Fig.   7A ) and splenic ( Fig. 8A ) atrophy in 1-week old animals. Although there was no marked changes in the percentage of T cell subsets upon THC treatment (Fig. 7B ), there was a significant decrease in the absolute number of most T cell subsets in the thymus of THC-exposed animals ( Fig. 7C) . Similarly, splenocytes from THC-exposed animals showed a significant decrease in proliferative response to ConA, LPS, and anti-CD3 mAb when compared to splenocytes from vehicle-exposed animals (Fig. 8B) . Together, these data demonstrated that subchronic perinatal exposure to THC, like acute perinatal exposure to THC, negatively affects the immune system of the progeny. This article has not been copyedited and formatted. The final version may differ from this version.
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Discussion
In this paper, we demonstrated that exposure to THC in utero can have long-term consequences on the immune system of the offspring. Indeed, we found that acute perinatal exposure to THC triggered fetal thymic atrophy, via CB1 and CB2 signaling and induction of apoptosis. There were significant changes in the fetal thymic subpopulations, leaving the offspring with lower absolute numbers of DP T cells. We found that this effect was dosedependent, and could still be detected on PD1. In addition, we demonstrated that acute perinatal exposure to THC leads to decreased immune response to HIV-1 p17/p24/gp-120. Finally, subchronic exposure to THC also led to impairment of the development and functions of thymus and the spleen.
Marijuana has been used recreationally for centuries, and research shows that it is the more commonly used drug of abuse in women of childbearing age worldwide (Hurd et al., 2005) .
Out of the 4% of US women acknowledging the use of illegal drugs during pregnancy, 75% admit to using marijuana (Hurd et al., 2005) . On the other hand, more and more studies are suggesting the use of marijuana and cannabinoids as therapeutic agents in the treatment of ailments ranging from multiple sclerosis and epilepsy Berdyshev, 2000) to certain types of cancer Berdyshev, 2000; McKallip et al., 2002a ). In addition, the approval of oral THC by the FDA to treat nausea in AIDS and cancer therapy patients has encouraged some to suggest the use of marijuana to relieve morning sickness during pregnancy (Westfall et al., 2006) . However, surveys in humans and studies in rodents suggest detrimental effects stemming from prenatal exposure to cannabinoids. Some studies report that children exposed to marijuana during pregnancy have a slower gestational growth rate (Hurd et al., 2005) Hurd et al., 2005) , as well are reduced gestational length (Fried et al., 1984; Hurd et al., 2005) . In addition, perinatal exposure to THC has been shown to affect brain development, resulting in an alteration in behavioral responses, both in rodents and in humans Vela et al., 1995; de Moraes Barros et al., 2006) (Patrini et al., 1997) , macrophages (Sacerdote et al., 2000) , and bone marrow-derived dendritic cells (DCs) (Do et al., 2004) , resulting in overall immunosuppression of the host (McKallip et al., 2002b; Do et al., 2004) . Such studies suggest that cannabinoids may serve as a double-edged sword, on one hand exhibiting the potential to treat inflammatory diseases, while on the other hand, potentially increasing the susceptibility to cancer and infections Rieder et al.; Nagarkatti et al., 2010) . In this paper, we show that perinatal exposure to THC negatively affects the immune system of the offspring, potentially compromising its response to infections. In particular, there is some evidence linking the use of marijuana to a higher risk of contracting HIV (Roth et al., 2005) .
However, not much work has been done to study how maternal use of marijuana during pregnancy affects the offspring's risk of getting infected with HIV. Our studies demonstrate that This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on August 10, 2011 as DOI: 10.1124/jpet.111.181206 at ASPET Journals on July 9, 2017 jpet.aspetjournals.org Downloaded from animals that have been exposed to THC in utero have a lower immune response to HIV at five weeks of age, as evidenced by a decreased proliferative response to HIV-1 p17/p24/gp-120 restimulation in vitro and lower HIV-1 p17/p24/gp-120 specific antibody titer in the serum. These data suggest that perinatal exposure to THC may increase the child's risk of contracting infections such as HIV.
Maternal transmission of HIV still remains a global concern. According to the Joint that intrauterine environmental factors that the offspring is exposed to during pregnancy could have a major impact on HIV transmission, immunosuppression and consequent increased susceptibility to disease in the children. It is therefore expected that the risk of HIV transmission increases with drug abuse by the mother. Our studies indicate for the first time that prenatal exposure to marijuana THC may cause immunosuppression in the fetus and the neonate thereby decreasing the ability of the newborn or neonate to fight against HIV infection acquired from maternal transmission.
Our initial experiments were conducted with an acute dose of THC due to the short gestation period of mice when compared to humans. However, we realize that perinatal exposure is more likely to be chronic due to repeated consumption of marijuana over an extended period of time during the pregnancy. Therefore we conducted experiments in which mice were exposed This article has not been copyedited and formatted. The final version may differ from this version.
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In most experiments, we observed significant effects with a single dose of 20 mg/kg injected on GD16. This translates to human equivalent dose of 60 mg/m 2 (1.6 mg/kg) based on the body surface area normalization (Reagan-Shaw et al., 2008) . The recommended dose of THC (dronabinol or Marinol) in cancer patients can be as high as 20 mg/m 2 /day (0.54 mg/kg), as an anti-emetic during chemotherapy. Rats injected with 50 mg/kg body weight of THC had a serum concentration of 10 mM THC within 10 h of administration (Chan et al., 1996) . In humans, levels as high as 1 mM in the plasma after recreational use of marijuana has been reported (Azorlosa et al., 1992) , which can preferentially get concentrated 15-20 fold in some tissues (Johansson et al., 1989) . Such levels of THC may cause significant impairment of immune cell function, and increased susceptibility to infections. An experimental dose of 8 mg/kg in mice has been shown to significantly suppress the response to Legionella pneumophila infection (Klein et al., 2000) . Overall, our results suggest that THC exposure during pregnancy at close to pharmacological or recreational dose can have significant effect and can impair the developing immune system of fetus.
We chose to treat the animals from GD16 onwards because this time-point corresponds to the initial stages of fetal T cell development, with TCR rearrangement, appearance of CD8 single positive T cells and expression of MHC on the stromal cells (Kingston et al., 1984; Haars et al., 1986; Pardoll et al., 1987) , and exposure to toxicants at this stage may greatly influence the development of the immune system. This article has not been copyedited and formatted. The final version may differ from this version.
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Because of its lipophilic properties, THC was initially thought to be acting via intercalation into the cell membrane. THC has now been shown to bind and signal through at least two G-protein coupled receptors, namely CB1 and CB2, although other receptors may exist (Berdyshev, 2000; Fride et al., 2003) . In this paper, we found that both CB1 and CB2 antagonists could prevent, at least in part, THC-induced thymic atrophy and apoptosis, suggesting the involvement of both receptors. It is still unclear whether THC affects the pups directly or indirectly by affecting the mother or placental transport. Cannabinoids have been shown to cross the placenta. Samples from the newborns such as hair, meconium, and plasma are often used to determine whether the child was exposed to marijuana in utero (Hutchings et al., 1989; Vinner et al., 2003) . Moreover, studies performed with pregnant dogs injected with radioactive THC intravenously showed that THC could be detected in the brains of both mother and offspring 30 min after the injection, suggesting that once it reaches the mother's bloodstream, THC can quickly reach the fetus (Martin et al., 1977) . In addition, our studies involving fetal thymic organ cultures confirmed the induction of apoptosis following exposure to THC in vitro, suggesting that perinatal exposure to THC may affect the fetal thymus directly.
The idea that perinatal insult may carry long lasting effects is not new. Relationship between low birth weight, which is the most common measure of fetal development, and the onset of high blood pressure, diabetes, stroke and cardiovascular diseases into adulthood, a phenomenon commonly known as the "fetal origins of adult disease" is known (Holladay, 1999) .
However, more and more studies are now focusing on the direct effects of perinatal exposure to toxicants on the immune system, showing that exposure during fetal development may have more severe consequences than exposure during adulthood (Holladay, 1999) . Studies from our This article has not been copyedited and formatted. The final version may differ from this version.
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24 laboratory and others have shown that perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces thymic atrophy and alterations in thymic subsets that can still be detected several days after exposure (Holladay, 1999; Camacho et al., 2004) . In addition, others have shown that mice that had been exposed to chlordane during fetal development had decreased delayed-type hypersensitivity and mixed-lymphocyte reactivity as adults (Urso and Gengozian, 1984) . The current study demonstrates for the first time that marijuana-abuse during pregnancy may impact the immune response of the fetus that could last into the adulthood.
Together, our studies suggest that pregnant women should be cautious about the decision to use cannabinoids whether for recreational or medicinal purposes as these could potentially have lifelong consequences for the health of their child. This is especially true if the mother is infected or at risk of being infected with HIV, inasmuch as our study suggests that perinatal exposure to THC could increase the risk of contracting the disease. This article has not been copyedited and formatted. The final version may differ from this version. Absolute numbers of cells for each subset per fetus are shown in C and expressed as mean ± SEM. Asterisk indicates statistically significant difference (p<0.05) in the mean cellularity of THC-exposed thymocytes when compared to the vehicle control. D) The thymocytes were analyzed for apoptosis using the TUNEL method followed by flow cytometric analysis as described in Methods. The percentage of apoptotic cells has been depicted in each histogram. 32 as mean ± SEM. In panels A, C, E, G and I, asterisk denotes statistically significant difference (p<0.05) between vehicle control and THC treatment group by two-tailed unpaired Student t-test. Organ Cultures (FTOCs) . FTOCs were prepared and exposed to THC or the vehicle as described in Methods. Thymi from fetuses of each mother were plated with up to 6 thymic lobes/well and at the time of harvesting, lobes from each well were pooled to prepare cell suspensions. Three such wells were used for each in vitro treatment.
Figure 5: Effects of THC on Fetal Thymic
On day 6, thymic lobes were harvested and pooled. A) Cell viability was determined using the trypan blue dye exclusion method. The data represent the mean thymic cellularity per organ ± SEM. Asterisk indicates statistically significant difference in the mean cellularity of THCexposed FTOCs when compared to the vehicle control. P=0.0002 by one-way ANOVA. B) The cells were analyzed for apoptosis using the TUNEL method followed by flow cytometry. The percentage of apoptotic cells has been depicted on each histogram. 33 statistically significant differences. A) One-way ANOVA, interaction : p=0.0005; DMSO vehicle vs THC: p=0.017; untreated vs gp-120 : p<0.0001. B) One-way ANOVA, interaction not significant; DMSO vs THC: not significant; untreated vs gp-120 : p=0.0016.
Figure 7:
Effect of subchronic perinatal exposure to THC on the thymus of one-week old pups. Groups of two C57BL/6 pregnant mice (n=2) were injected with 25 mg/kg THC or the vehicle on GD16, and 10 mg/ml THC or the vehicle every day thereafter until they delivered the pups (for a total of 4 injections, or 55 mg/kg THC). One week after the pups were born, the thymi were harvested and pooled for each mother (average 10 pups per mother). Groups of two C57BL/6 pregnant mice (n=2) were injected with 25 mg/kg THC or the vehicle on GD16, and 10 mg/ml THC or the vehicle every day thereafter until they delivered the pups (for a total of 4 injections, or 55 mg/kg THC). One week after the pups were born, the spleens were harvested and pooled for each mother (average 10 pups per mother). A) Splenic This article has not been copyedited and formatted. The final version may differ from this version. 
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